InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
3
T+90 hit rate
20%
T+90 mean return
-16.6%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Sablich Kim. Insider active across 2 companies, notably Jazz Pharmaceuticals plc. Cumulatively, 10 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €878k. Activity tracked since 5 June 2021. The latest transaction was disclosed on 5 June 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
2,082 shares@ US$129.7314.0% of flowOrdinary SharesSEC:0001765581-23-000046:0
1,752 shares@ US$139.4212.9% of flowOrdinary SharesSEC:0001765581-23-000036:0
10,429 shares0Ordinary SharesSEC:0001765581-23-000017:0
1,759 shares@ US$149.250.0017% mcap18.7% of flowOrdinary SharesSEC:0001765581-22-000057:0
6,000 shares0Common StockSEC:0001140361-22-009263:0
9,953 shares0Ordinary SharesSEC:0001765581-22-000028:0
2,748 shares@ US$135.00740.0023% mcap24.6% of flowOrdinary SharesSEC:0001765581-21-000125:0
2,748 shares@ US$135.007418.0% of flowOrdinary SharesSEC:0001765581-21-000125
1,452 shares@ US$176.470.0015% mcap16.1% of flowOrdinary SharesSEC:0001765581-21-000061:0
1,452 shares@ US$176.4711.7% of flowOrdinary SharesSEC:0001765581-21-000061
10 of 10 declarations
About Sablich Kim
Sablich Kim is a director at Jazz Pharmaceuticals plc and Eiger BioPharmaceuticals, Inc.
